Ftse Mib
34.492,41
0,13%
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
NASDAQ
16.735,02
-0,01%
Bitcoin
67.618,85
0,20%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Inspira Technologies Oxy B H N Ltd (IINN) Inspira Technologies Oxy B H N Ltd (IINN) Notizie

IINN

Inspira Technologies Oxy... (IINN)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:IINN
DataOraFonteTitoloSimboloCompagnia
30/05/202414:30PR Newswire (US)Inspira™ Technologies Announces Business Targets Presentation Following FDA Clearance and Significant DevelopmentsNASDAQ:IINNInspira Technologies Oxy B H N Ltd
28/05/202415:25PR Newswire (US)INSPIRA™ ART100 Receives FDA 510(k) ClearanceNASDAQ:IINNInspira Technologies Oxy B H N Ltd
02/05/202415:18PR Newswire (US)Inspira™ Announces Start of Production of the INSPIRA™ ART100NASDAQ:IINNInspira Technologies Oxy B H N Ltd
25/04/202414:00PR Newswire (US)Inspira™ Receives CSA Certification of Compliance to U.S. Standards for the INSPIRA™ ART100NASDAQ:IINNInspira Technologies Oxy B H N Ltd
16/04/202414:42PR Newswire (US)Inspira™ Signs Term Sheet for Use of INSPIRA™ ART100 Device in Organ Transplant ProceduresNASDAQ:IINNInspira Technologies Oxy B H N Ltd
10/04/202414:24PR Newswire (US)Inspira™ and Ennocure In Vitro Study Results Show 100% Prevention of Bacterial Growth that Causes Bloodstream InfectionsNASDAQ:IINNInspira Technologies Oxy B H N Ltd
03/04/202414:30PR Newswire (US)Inspira™ Announces Program to Pioneer the Applicable Use of the INSPIRA™ ART100 Device for an Artificial WombNASDAQ:IINNInspira Technologies Oxy B H N Ltd
01/04/202414:00PR Newswire (US)Inspira™ Announces $1.65 Million Registered Direct Offering of Ordinary Shares by Inspira CEO's Mother with Leading Fund ManagerNASDAQ:IINNInspira Technologies Oxy B H N Ltd
25/03/202414:20PR Newswire (US)Inspira™ Technologies Reports Full Year 2023 Financial ResultsNASDAQ:IINNInspira Technologies Oxy B H N Ltd
18/03/202412:00PR Newswire (US)Inspira™ Announces AMAR Regulatory Submission of the INSPIRA™ ART100, to Enter the Southeast Asia and South American MarketsNASDAQ:IINNInspira Technologies Oxy B H N Ltd
12/03/202413:00PR Newswire (US)Inspira™ Releases New Data Demonstrating Superiority of its Core Technology, Across Key Endpoints of HMSS IndicatorNASDAQ:IINNInspira Technologies Oxy B H N Ltd
08/03/202422:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IINNInspira Technologies Oxy B H N Ltd
04/03/202415:20PR Newswire (US)Inspira™ Announces Plans to Report the Primary Results for a Core Blood Oxygenation Technology Within DaysNASDAQ:IINNInspira Technologies Oxy B H N Ltd
27/02/202413:02PR Newswire (US)Inspira™ To Host Conference Call to Discuss Investor Presentation and Announce Next Major MilestoneNASDAQ:IINNInspira Technologies Oxy B H N Ltd
27/02/202413:00PR Newswire (US)Inspira™ Announces Breakthrough Update: Nears First FDA 510(k) Approval, 3 U.S. Patents Approved, $546 million in Summary Distribution AgreementsNASDAQ:IINNInspira Technologies Oxy B H N Ltd
22/02/202413:00PR Newswire (US)Inspira™ introduces high-end platform for bio-mimicking blood parameters for development and testing of core technologiesNASDAQ:IINNInspira Technologies Oxy B H N Ltd
14/02/202413:30PR Newswire (US)Inspira™ Receives First Ever U.S. Patent Approval for an Orbiting Blood Oxygenation Delivery SystemNASDAQ:IINNInspira Technologies Oxy B H N Ltd
12/02/202422:05Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:IINNInspira Technologies Oxy B H N Ltd
08/02/202415:00PR Newswire (US)Inspira™ Technologies Collaborates with a Leading Israeli Medical Center for Clinical Evaluation of INSPIRA™ ART DeviceNASDAQ:IINNInspira Technologies Oxy B H N Ltd
30/01/202414:30PR Newswire (US)Inspira™ Technologies Signs Strategic Agreement to Enter Gulf States with Glo-Med for Deployment of 531 INSPIRA™ ART DevicesNASDAQ:IINNInspira Technologies Oxy B H N Ltd
09/01/202414:30PR Newswire (US)Inspira™ Announces Plans to Launch and Target Single-Use Disposable Blood Oxygenation Kit for a New Disposable Perfusion Market OpportunityNASDAQ:IINNInspira Technologies Oxy B H N Ltd
02/01/202414:30PR Newswire (US)Inspira™ Technologies Signs Letter of Intent with Northwestern Memorial Hospital in Chicago for Clinical Use of INSPIRA™ ART100 DeviceNASDAQ:IINNInspira Technologies Oxy B H N Ltd
28/12/202322:01PR Newswire (US)Inspira™ Technologies Closes on $3.88 Million Registered Direct OfferingNASDAQ:IINNInspira Technologies Oxy B H N Ltd
28/12/202315:28Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:IINNInspira Technologies Oxy B H N Ltd
26/12/202320:16PR Newswire (US)Inspira Announces $3.88 Million Registered Direct OfferingNASDAQ:IINNInspira Technologies Oxy B H N Ltd
26/12/202314:45PR Newswire (US)Inspira™ Announces 95% Accuracy Results for HYLA™ Blood Sensor, Planning FDA Submission for Clearance in 2024NASDAQ:IINNInspira Technologies Oxy B H N Ltd
18/12/202314:30PR Newswire (US)Inspira Technologies to Participate in J.P. Morgan Healthcare ConferenceNASDAQ:IINNInspira Technologies Oxy B H N Ltd
11/12/202315:00PR Newswire (US)In Preparation for FDA Clearance and Device Deployment, Inspira has Appointed Dr. Dan Gorfil, to Medical Advisory BoardNASDAQ:IINNInspira Technologies Oxy B H N Ltd
29/11/202315:02PR Newswire (US)Inspira Collaborates with Ennocure for development of a Proprietary Bio-Electronic Treatment to Prevent Associated Bloodstream Infections in ICU PatientsNASDAQ:IINNInspira Technologies Oxy B H N Ltd
16/11/202315:40PR Newswire (US)Inspira™ Technologies Reports Third Quarter 2023 Financial ResultsNASDAQ:IINNInspira Technologies Oxy B H N Ltd
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:IINN

La tua Cronologia

EU
ZSN5D
Euronext Eurozone SBT 15...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network